Effect of beclomethasone dipropionate in chronic bronchial asthma
| dc.contributor.author | Tin Nu Swe | en_US |
| dc.contributor.author | Myo Thwe | en_US |
| dc.date.accessioned | 2009-06-10T17:26:13Z | |
| dc.date.available | 2009-06-10T17:26:13Z | |
| dc.date.created | 1982-01-01 | en_US |
| dc.date.issued | 1982-01-01 | en_US |
| dc.description.abstract | Beclomethasone dipropionate (Aldecin) 2 x 50ug x 4 times/day given by inhalation was compared with control involving forty patients (20 study patients and 20 control patients) with chronic bronchial asthma. The period of study for each patient being 8 weeks. Improvement was assessed by diary score cards with its criteria, daily peak flow rates and other pulmonary function tests. Significant improvement was seen by each of these criteria. Although improvement was obvious during the first month of Beclomethasone dipropionate therapy in (he majority of studied patients, a more definite benefit was seen during the second month in terms of symptom scores and daily peak flow rate and FEV 1studies. There was no evidence of any deleterious effects from the drug: There results indicate that Becfomethasone dipropionate (Aldecin) given by inhalation in a dose of 400ug per day promises to be an effective treatment in patients with Bronchial Asthma). | en_US |
| dc.identifier.citation | Tin Nu Swe, Myo Thwe. Effect of beclomethasone dipropionate in chronic bronchial asthma. Burma Medical Journal. 1982; 28(2): 162-169 | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/126179 | |
| dc.subject.mesh | Asthma | en_US |
| dc.subject.mesh | Beclomethasone | en_US |
| dc.title | Effect of beclomethasone dipropionate in chronic bronchial asthma | en_US |
Files
License bundle
1 - 1 of 1